Symptoms of Low Coenzyme Q10 (CoQ10): Causes and Treatment
Deficiency
Symptoms & causes
A genuine CoQ10 deficiency does exist — but it's a rare genetic disorder diagnosed in infancy, not a common adult condition from poor diet. Statin users may have lower levels, but trials haven't confirmed CoQ10 relieves statin-related muscle aches.
Coenzyme Q10 is a vital compound your body produces naturally, playing a key role in energy production within your cells. While a true, primary CoQ10 deficiency is a rare and serious genetic disease, the term is often misused in supplement marketing to describe age-related decline or lower levels from statin use. This page separates the clinical reality from the common claims, so you can understand what the science actually says about symptoms, causes, and whether supplementation is necessary.
This is general nutrition and wellness information, not medical advice. If you're on a weight-loss medication or managing a health condition, confirm specifics with your clinician.
Symptoms of low Coenzyme Q10 (CoQ10, ubiquinone/ubiquinol) — an essential cofactor in the mitochondrial respiratory chain (electron carrier in oxidative phosphorylation) and a lipid-soluble antioxidant in all cell membranes.
Everyday signs are on the left; the ones on the right mean it's time to check in with a clinician.
Everyday signs
Common symptoms
- Exercise intolerance
- Fatigue
- Elevated creatine kinase — in primary genetic CoQ10 deficiency or secondary mitochondrial disease
- Muscle weakness
- Myopathy phenotype
Don't wait
See a doctor if
- Muscle weakness with elevated creatine kinase
- Recurrent myoglobinuria (dark/red urine after exercise)
- Unexplained cerebellar ataxia
- Severe multisystem symptoms in infants (encephalomyopathy, renal tubular dysfunction). These are rare — seek specialist evaluation.
Who is most likely to run low
Some people are more prone to falling short than others — including many people on a weight-loss journey who are simply eating less.
- People with inherited mitochondrial disorders
- CoQ10 levels decline with age (normal aging)
- Statin users may have lower circulating levels
What causes low Coenzyme Q10 (CoQ10, ubiquinone/ubiquinol) — an essential cofactor in the mitochondrial respiratory chain (electron carrier in oxidative phosphorylation) and a lipid-soluble antioxidant in all cell membranes.
- Primary: Genetic defects in ubiquinone biosynthesis genes (rare inborn error of metabolism; several subtypes).
- Secondary: Mitochondrial disease or disorders; statin medication use associated with lower plasma CoQ10 levels (mechanism: statins inhibit the same HMG-CoA reductase pathway used in CoQ10 synthesis).
How low levels are diagnosed
Plasma CoQ10 level (Mayo Clinic Laboratories offers the test); muscle biopsy in specialist context; genetic testing for biosynthesis gene mutations.
How it's corrected
Most gaps close with food first, and supplementation when a clinician recommends it.
Present in meat, fish, and some plant foods (beef heart and liver are richest; nuts and legumes are modest sources). Dietary amounts are small relative to supplements. Supplementation is available as ubiquinone (oxidized) and ubiquinol (reduced, thought to be more bioavailable in older adults). Clinical deficiency managed under medical supervision — doses in genetic deficiency are high and physician-directed.
How to keep levels up
Not preventable (primary deficiency is genetic). Levels decline with age — no proven prevention. If on statins, discuss CoQ10 with your clinician (evidence for muscle-ache benefit is mixed in double-blind trials).
When to see a clinician
For unexplained muscle weakness, elevated CK, myoglobinuria, neurological symptoms, or any multisystem presentation — particularly in children. Statin-related muscle pain warrants clinician discussion (not self-supplementation).
The Two Very Different Meanings of 'Low CoQ10': Rare Disease vs. Common Marketing Claim
When you search for 'low CoQ10 symptoms,' you'll quickly find two completely different conversations happening — one in medical textbooks and one on supplement bottles. The medical reality is a rare, serious genetic disease; the marketing reality is a far broader and less substantiated claim about common fatigue and aging.
Primary CoQ10 deficiency is a group of autosomal recessive disorders caused by mutations in genes responsible for ubiquinone biosynthesis. It typically presents in infancy or early childhood with severe, multisystem involvement: encephalomyopathy, cerebellar ataxia, steroid-resistant nephrotic syndrome, and hypertrophic cardiomyopathy. This is a diagnosis made by metabolic specialists, confirmed by genetic testing and muscle biopsy — not by a symptom quiz online.
The supplement industry, however, has co-opted the term 'deficiency' to describe the gradual, age-related decline in CoQ10 levels or the measurable drop seen in statin users. These are real biochemical observations, but they do not constitute a deficiency disease. Conflating the two is misleading and can send healthy adults down a path of self-supplementation for symptoms that need proper medical evaluation.
This distinction matters enormously. If you're an adult experiencing fatigue, muscle aches, or brain fog, attributing those symptoms to 'low CoQ10' without ruling out far more common causes — iron deficiency, thyroid dysfunction, sleep apnea, depression — is a diagnostic error, not a biohack.
Bottom line
A true CoQ10 deficiency is a rare genetic disorder with a specific clinical phenotype — not a diagnosis applicable to most adults who feel tired. The label 'low CoQ10' means two entirely different things in medical literature vs. supplement marketing.
CoQ10 and Statins: What the Evidence Actually Says
Statins inhibit HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis. That same pathway is also required for the body's own production of CoQ10. The biochemical consequence is predictable: people taking statins show measurably lower plasma CoQ10 concentrations. This is not controversial — it's well-documented physiology.
The leap from 'lower plasma CoQ10' to 'CoQ10 supplements fix statin muscle pain' is where the evidence gets shaky. Multiple double-blind, randomized controlled trials have tested CoQ10 supplementation for statin-associated muscle symptoms, and the results have been inconsistent at best. A 2018 meta-analysis in the Journal of the American Heart Association found no significant benefit for muscle pain. Some individuals do report improvement, and the supplement is low-risk, but the data do not support a universal recommendation.
Part of the complexity is that plasma CoQ10 levels don't necessarily reflect intramuscular CoQ10 concentrations. It's possible that statins deplete plasma CoQ10 without causing a functional deficit in muscle tissue — or that muscle symptoms arise through other mechanisms entirely. Until this is clarified, CoQ10 remains a 'try it and see' option under clinical guidance, not a proven antidote.
If you're on a statin and experiencing muscle pain, do not stop your medication. Statins have robust, life-saving cardiovascular benefits. The right move is a conversation with your prescribing clinician, who can assess whether a dose adjustment, a switch to a different statin, or a trial of CoQ10 makes sense for you.
Bottom line
Statins do lower plasma CoQ10 levels. However, randomized trials have not clearly shown that CoQ10 supplements relieve statin-related muscle aches in most people. Discuss with your prescribing clinician before stopping a statin.
Age-Related Decline in CoQ10: Is It Clinically Meaningful?
CoQ10 levels in blood and tissue peak around age 20 and decline steadily thereafter. By age 80, myocardial CoQ10 concentrations can be roughly half of what they were in young adulthood. This is a consistent finding across studies and is not disputed.
What is disputed is whether this decline actively drives the aging process or is simply a biomarker of it — a passenger, not a driver. The anti-aging supplement industry has enthusiastically embraced the driver hypothesis, marketing CoQ10 as a mitochondrial rejuvenator. The evidence for this in healthy aging humans is thin. Observational studies show associations between higher CoQ10 levels and better outcomes, but association is not causation.
The most intriguing clinical data come from heart failure research. The Q-SYMBIO trial, a randomized controlled study of 420 patients, found that CoQ10 supplementation reduced major adverse cardiovascular events and all-cause mortality in chronic heart failure. While these results are promising, they have not been replicated in a large, multicenter trial, and CoQ10 is not part of standard heart failure guidelines. It's a signal worth watching, not a settled conclusion.
For otherwise healthy adults concerned about aging, the honest answer is that CoQ10 supplementation has not been proven to slow aging, boost energy, or prevent disease. A balanced diet, regular exercise, and managing cardiovascular risk factors have far stronger evidence behind them.
Bottom line
Age-related decline in CoQ10 is real but its clinical significance for otherwise healthy people is uncertain. The heart failure data are intriguing but not practice-changing per most cardiology guidelines.
Ubiquinone vs. Ubiquinol: Does the Form You Take Matter?
CoQ10 exists in two forms in the body: ubiquinone (the oxidized form) and ubiquinol (the reduced, active antioxidant form). Most CoQ10 in circulation is ubiquinol, and the body interconverts between the two. Supplement manufacturers offer both, often charging a premium for ubiquinol with claims of superior absorption.
The absorption claim has some basis. Several pharmacokinetic studies show that ubiquinol supplements raise plasma CoQ10 levels more efficiently than equivalent doses of ubiquinone. This difference is most pronounced in older adults, who may have a reduced capacity to convert ubiquinone to ubiquinol. If your goal is simply to raise blood levels, ubiquinol is the more efficient vehicle.
But here's the critical question that marketing materials tend to skip: does a higher plasma level translate to a better clinical outcome? The answer, for most conditions, is unknown. The trials that have shown possible benefit — like Q-SYMBIO for heart failure — used ubiquinone, not ubiquinol. No large outcome trial has compared the two forms head-to-head for any clinical endpoint.
If you and your clinician decide on a trial of CoQ10, ubiquinol may be a reasonable choice for bioavailability reasons, especially if you're over 50. But don't mistake better blood levels for proven superiority in health outcomes. That evidence simply doesn't exist yet.
Bottom line
Ubiquinol raises plasma CoQ10 more efficiently than ubiquinone, particularly in older adults. Whether this matters for health outcomes is less clear than the marketing suggests.
CoQ10 for GLP-1 Users: Muscle Health, Fatigue, and Honest Expectations
Some people taking GLP-1 receptor agonists like semaglutide or tirzepatide report fatigue, particularly during the early months of treatment. This is not surprising — significant caloric restriction, shifts in macronutrient intake, and rapid weight loss all place demands on the body that can manifest as tiredness. The question is whether CoQ10 has any role in addressing this.
There is no direct evidence that CoQ10 supplementation improves energy levels or muscle symptoms specifically in GLP-1 users. The fatigue associated with GLP-1 therapy is more plausibly explained by reduced caloric intake, potential dehydration from gastrointestinal side effects, and the metabolic adaptation to weight loss. These are not CoQ10 deficiency states.
Where the CoQ10 conversation becomes relevant for GLP-1 users is in the context of statin use. Many people prescribed GLP-1 agonists for weight management also have cardiovascular risk factors that warrant statin therapy. If you're on both medications and experiencing muscle aches or weakness, the statin is the more likely culprit — and the evidence for CoQ10 as a remedy is, as discussed, mixed.
The bottom line: don't self-prescribe CoQ10 to fix GLP-1-related fatigue. Focus on adequate protein intake, hydration, electrolyte balance, and sleep. If muscle symptoms are prominent and you're on a statin, have a structured conversation with your clinician. They can help distinguish statin myalgia from the normal adjustments to weight loss and caloric deficit.
Bottom line
There is no evidence CoQ10 supplementation improves GLP-1 therapy outcomes. If you're on both a statin and GLP-1 therapy and experiencing muscle symptoms, that's a clinician conversation — not an OTC supplement decision.
What most pages leave out
The vast majority of CoQ10 supplement marketing implies 'deficiency' is common in adults and that supplementation corrects fatigue, aging, or muscle pain. The clinical reality: true deficiency is a rare genetic disease; statin-CoQ10 muscle benefit is not confirmed in double-blind trials; age-related decline does not constitute a deficiency syndrome. Q-SYMBIO heart failure data are interesting but not guideline-level. Honest pages must not sell the consumer on a supplement solution to symptoms that need clinical evaluation.
We flag this so you can make an informed choice — not to scare you off.
❓Frequently Asked Questions
Genuine CoQ10 deficiency, a rare genetic disorder, causes muscle weakness, exercise intolerance, ataxia, and multisystem features — diagnosed by specialists. Common adult fatigue is not a CoQ10 deficiency symptom in the clinical sense.
Yes — statins measurably lower plasma CoQ10 levels via the HMG-CoA reductase pathway. However, randomized trials have not consistently shown CoQ10 supplements relieve statin-related muscle pain.
Plasma CoQ10 can be measured by specialty laboratories like Mayo Clinic Laboratories. Routine testing is not standard practice; it's used in specialist evaluation of suspected mitochondrial disorders.
Ubiquinol raises plasma CoQ10 more efficiently, particularly in older adults. Whether this translates to better clinical outcomes is less clear than the marketing suggests.
CoQ10 is often marketed for fatigue, but evidence in otherwise healthy adults is limited. Fatigue has many causes — thyroid, iron, sleep, depression — that should be evaluated before attributing it to CoQ10 status.
Beef heart and liver, fatty fish (salmon, sardines, mackerel), pork, chicken, and nuts. Dietary amounts are modest compared to supplements.
The Q-SYMBIO trial found possible benefit for heart failure outcomes with CoQ10 supplementation. The evidence is considered preliminary by most cardiology guidelines; discuss with a cardiologist.
No established pharmacological interaction. If you're on a statin and GLP-1 therapy and have muscle symptoms, discuss the full picture with your clinician before adding CoQ10.
Medically reviewed by
Chet Tharpe, MDBoard-certified physician
Last reviewed July 2026
Related Articles
What Are the Symptoms of Low Aloe Vera? Causes and Treatment
Aloe vera is a plant, not a nutrient—no deficiency exists. Learn the critical gel vs. latex safety distinction, FDA actions, and oral use risks for GLP-1 users.
Read moreSymptoms of Low Barley Grass: Why This Isn’t a Real Deficiency
Barley grass is a plant food, not an essential nutrient. There is no barley grass deficiency. Learn what it actually contains, what the weak evidence shows, and the real safety risks.
Read moreSymptoms of Low 5-HTP (5-Hydroxytryptophan): Causes & Treatment
5-HTP is a serotonin precursor, not a nutrient you can be deficient in. Learn what low serotonin activity means, the real risks of 5-HTP supplements, and safer alternatives.
Read moreSymptoms of Low Astaxanthin: Causes and Treatment
Astaxanthin is a powerful antioxidant found in salmon and shrimp, but there's no such thing as a deficiency. Learn what low intake actually means and what the science says.
Read moreSymptoms of Low Apple Cider Vinegar: Causes and Treatment
Apple cider vinegar is a condiment, not a nutrient — no deficiency syndrome exists. Learn what the research actually shows about ACV, blood sugar, and safety risks.
Read moreSymptoms of Low Ashwagandha: Causes and Treatment
Ashwagandha is an adaptogenic herb, not a nutrient. No deficiency syndrome exists. Learn what the evidence shows for stress, thyroid, and safety risks like thyrotoxicosis.
Read moreOn a GLP-1, or thinking about one?
Nutrient gaps are more common on a GLP-1 because you eat less — care that includes real clinical oversight helps you do it safely.Curex connects you with licensed clinicians for compounded GLP-1 medications, if it's right for you.
- Compounded semaglutide from $49/mo, tirzepatide from $149/mo
- Prescribed by licensed clinicians after an online visit
- Delivered to your door — no in-person clinic required
This content is for general informational purposes only and is not medical or nutritional advice, a diagnosis, or a substitute for professional judgment. It does not account for your health, medications, or goals, and nutrition information changes over time. Always talk with a qualified clinician or dietitian before making significant changes to your diet, supplements, or medications. Curex offers compounded GLP-1 medications through licensed clinicians and does not sell or endorse the food or supplement reviewed on this page.